ArticleNanoscale advances2022
Hydrothermal synthesis and characterization of the antimony-tin oxide nanomaterial and its application as a high-performance asymmetric supercapacitor, photocatalyst, and antibacterial agent.
Article in Nanoscale advances, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Polyindole-Functionalized RGO-NiFePolymers · 2024Article
- Highly selective CONanoscale advances · 2023Article
- The Antibiofilm Effects of Antimony Tin Oxide Nanoparticles against Polymicrobial Biofilms of UropathogenicPharmaceutics · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We have synthesized antimony-tin oxide (ATO) nanoparticles chemically for use in antibacterial, photocatalytic, and supercapacitor applications. The XRD pattern reveals the hexagonal structure, while the FTIR spectra validate the functional groups. The agglomerated nanostructures, which are 40-50 nm thick and 100 nm long, are shown in the SEM images as having spherical, cube, square, and rod form morphologies. In a DLS test, ATO has a zeta potential of 28.93/-28.00 mV, demonstrating strong colloidal stability in the suspension. With minimum inhibitory concentrations (MIC) ranging from 25 to 100 g mL
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.